$KYMR
Kymera Therapeutics, Inc.

2023 Q3 Form 10-Q Financial Statement

#000095017023037581 Filed on August 03, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $4.728M $16.51M
YoY Change -50.5% 43.42%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $14.12M $14.13M
YoY Change 33.76% 28.08%
% of Gross Profit
Research & Development $48.12M $45.77M
YoY Change 9.66% 10.83%
% of Gross Profit
Depreciation & Amortization $900.0K $900.0K
YoY Change 112400.0% 28.57%
% of Gross Profit
Operating Expenses $62.24M $59.90M
YoY Change 14.34% 14.47%
Operating Profit -$57.51M -$43.38M
YoY Change 28.13% 6.3%
Interest Expense $4.640M $4.584M
YoY Change 146.81% 728.93%
% of Operating Profit
Other Income/Expense, Net $4.642M $4.584M
YoY Change 146.91% 728.93%
Pretax Income -$52.87M -$38.80M
YoY Change 22.95% -3.62%
Income Tax $100.0K $100.0K
% Of Pretax Income
Net Earnings -$52.87M -$38.80M
YoY Change 22.94% -3.62%
Net Earnings / Revenue -1118.17% -234.96%
Basic Earnings Per Share -$0.90 -$0.67
Diluted Earnings Per Share -$0.90 -$0.67
COMMON SHARES
Basic Shares Outstanding 55.41M 55.31M
Diluted Shares Outstanding 58.42M 58.33M

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $357.8M $367.6M
YoY Change -25.75% -6.3%
Cash & Equivalents $81.05M $52.39M
Short-Term Investments $276.8M $315.2M
Other Short-Term Assets $14.10M $13.71M
YoY Change 52.73% 69.4%
Inventory
Prepaid Expenses
Receivables $3.800M $4.122M
Other Receivables $0.00 $0.00
Total Short-Term Assets $375.7M $385.4M
YoY Change -23.95% -4.31%
LONG-TERM ASSETS
Property, Plant & Equipment $36.15M $27.49M
YoY Change 187.57% 115.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $77.00M $104.8M
YoY Change -32.28% 16.16%
Other Assets $2.802M $2.802M
YoY Change -7.1% 15.45%
Total Long-Term Assets $176.7M $196.5M
YoY Change 22.31% 62.9%
TOTAL ASSETS
Total Short-Term Assets $375.7M $385.4M
Total Long-Term Assets $176.7M $196.5M
Total Assets $552.4M $581.9M
YoY Change -13.48% 11.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.978M $3.745M
YoY Change -21.32% 57.75%
Accrued Expenses $26.38M $22.49M
YoY Change 6.85% 3.46%
Deferred Revenue $27.35M $24.30M
YoY Change -50.96% -59.13%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $1.000M $1.231M
YoY Change -9.34% 6.3%
Total Short-Term Liabilities $63.17M $54.60M
YoY Change -30.68% -37.6%
LONG-TERM LIABILITIES
Long-Term Debt $600.0K $762.0K
YoY Change -13.04% -17.8%
Other Long-Term Liabilities $8.000K $230.0K
YoY Change -96.88% -12.88%
Total Long-Term Liabilities $8.000K $230.0K
YoY Change -96.88% -12.88%
TOTAL LIABILITIES
Total Short-Term Liabilities $63.17M $54.60M
Total Long-Term Liabilities $8.000K $230.0K
Total Liabilities $156.8M $146.5M
YoY Change 24.89% 16.77%
SHAREHOLDERS EQUITY
Retained Earnings -$516.4M -$463.5M
YoY Change 48.01% 51.52%
Common Stock $914.4M $902.6M
YoY Change 5.38% 27.51%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $395.5M $435.4M
YoY Change
Total Liabilities & Shareholders Equity $552.4M $581.9M
YoY Change -13.48% 11.18%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income -$52.87M -$38.80M
YoY Change 22.94% -3.62%
Depreciation, Depletion And Amortization $900.0K $900.0K
YoY Change 112400.0% 28.57%
Cash From Operating Activities -$31.70M -$35.26M
YoY Change -7.5% -9.57%
INVESTING ACTIVITIES
Capital Expenditures $8.100M $10.77M
YoY Change -750.08% -1565.03%
Acquisitions
YoY Change
Other Investing Activities $68.60M $46.61M
YoY Change -289.32% -43.53%
Cash From Investing Activities $60.50M $35.84M
YoY Change -261.42% -56.19%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -200.0K 1.305M
YoY Change -100.13% 258.52%
NET CHANGE
Cash From Operating Activities -31.70M -35.26M
Cash From Investing Activities 60.50M 35.84M
Cash From Financing Activities -200.0K 1.305M
Net Change In Cash 28.60M 1.888M
YoY Change -63.68% -95.63%
FREE CASH FLOW
Cash From Operating Activities -$31.70M -$35.26M
Capital Expenditures $8.100M $10.77M
Free Cash Flow -$39.80M -$46.02M
YoY Change 20.52% 20.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
kymr Net Operating Loss Carryforwards Period Cares Act
NetOperatingLossCarryforwardsPeriodCARESAct
P5Y
CY2022Q2 us-gaap Change In Accounting Principle Accounting Standards Update Adopted
ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
true
dei Entity Central Index Key
EntityCentralIndexKey
0001815442
CY2022Q2 us-gaap Change In Accounting Principle Accounting Standards Update Immaterial Effect
ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
true
CY2023Q2 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2022Q2 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#RelatedPartyMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#RelatedPartyMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2023#RelatedPartyMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39460
dei Entity Registrant Name
EntityRegistrantName
KYMERA THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2992166
dei Entity Address Address Line1
EntityAddressAddressLine1
200 Arsenal Yards Blvd
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 230
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
285-5300
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
KYMR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
55412304
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52386000
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
68395000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
315188000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
338771000
CY2023Q2 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
4122000
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
2537000
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
13706000
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9713000
CY2023Q2 us-gaap Assets Current
AssetsCurrent
385402000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
419416000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
104759000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
152328000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27494000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13334000
CY2023Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
55687000
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8909000
CY2023Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2802000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
3017000
CY2023Q2 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5801000
CY2022Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
6130000
CY2023Q2 us-gaap Assets
Assets
581945000
CY2022Q4 us-gaap Assets
Assets
603134000
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
3745000
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4335000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22490000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27502000
CY2023Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
24302000
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
35260000
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2566000
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
2535000
CY2023Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1231000
CY2022Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1408000
CY2023Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
268000
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
303000
CY2023Q2 us-gaap Liabilities Current
LiabilitiesCurrent
54602000
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
71343000
CY2023Q2 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
20421000
CY2022Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
28000000
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70502000
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12146000
CY2023Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
762000
CY2022Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1246000
CY2023Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
230000
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
248000
CY2023Q2 us-gaap Liabilities
Liabilities
146517000
CY2022Q4 us-gaap Liabilities
Liabilities
112983000
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55390259
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55390259
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55039380
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55039380
CY2023Q2 us-gaap Common Stock Value
CommonStockValue
6000
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2023Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
902574000
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
878884000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-463517000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-383790000
CY2023Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3635000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-4949000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
435428000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
490151000
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
581945000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
603134000
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16513000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11514000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
25979000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
21136000
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45767000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
41293000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
87994000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
77238000
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14129000
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11031000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26694000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21642000
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
59896000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
52324000
us-gaap Operating Expenses
OperatingExpenses
114688000
us-gaap Operating Expenses
OperatingExpenses
98880000
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-43383000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-40810000
us-gaap Operating Income Loss
OperatingIncomeLoss
-88709000
us-gaap Operating Income Loss
OperatingIncomeLoss
-77744000
CY2023Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4632000
CY2022Q2 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
594000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9085000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
884000
CY2023Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
48000
CY2022Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
41000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
103000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
81000
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4584000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
553000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
8982000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
803000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38799000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-40257000
us-gaap Net Income Loss
NetIncomeLoss
-79727000
us-gaap Net Income Loss
NetIncomeLoss
-76941000
CY2023Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-597000
CY2022Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-767000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1314000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-3323000
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-39396000
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-41024000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-78413000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-80264000
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-38799000
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-40257000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-79727000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-76941000
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58326963
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58326963
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51772440
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51772440
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58257387
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58257387
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51712081
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51712081
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
428720000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
377000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
256000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9622000
CY2022Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-767000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-40257000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
397951000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
462005000
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
676000
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
962000
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11181000
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-597000
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38799000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
435428000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
459638000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
826000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
256000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17495000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-3323000
us-gaap Net Income Loss
NetIncomeLoss
-76941000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
397951000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
490151000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2163000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
962000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20565000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1314000
us-gaap Net Income Loss
NetIncomeLoss
-79727000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
435428000
us-gaap Profit Loss
ProfitLoss
-79727000
us-gaap Profit Loss
ProfitLoss
-76941000
us-gaap Share Based Compensation
ShareBasedCompensation
20565000
us-gaap Share Based Compensation
ShareBasedCompensation
17495000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1779000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1392000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
-2743000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
1852000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3994000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-630000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
1585000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
2234000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-513000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1847000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-6252000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1720000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-18537000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-17503000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-2055000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-245000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
9554000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-479000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-174000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
170000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79224000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-79280000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
14777000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1217000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
114477000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
144827000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
189677000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
253710000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
60423000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
107666000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2163000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
826000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
962000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
256000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
661000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
533000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2464000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
549000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16337000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
28935000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74524000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54092000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58187000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
83027000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48833000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Interest Paid Net
InterestPaidNet
78000
us-gaap Interest Paid Net
InterestPaidNet
86000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
1061000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
745000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
0
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
340000
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52386000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76914000
CY2023Q2 us-gaap Restricted Cash
RestrictedCash
5801000
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
6113000
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
58187000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
83027000
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-463500000
CY2023Q2 us-gaap Investments And Cash
InvestmentsAndCash
472300000
CY2023Q2 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2022Q4 kymr Fair Value Assets Level1 To Level3 Transfers Amount
FairValueAssetsLevel1ToLevel3TransfersAmount
0
CY2023Q2 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2022Q4 kymr Fair Value Assets Level3 To Level1 Transfers Amount
FairValueAssetsLevel3ToLevel1TransfersAmount
0
CY2023Q2 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2022Q4 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2023Q2 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2022Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2023Q2 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
423586000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
4000
CY2023Q2 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
3643000
CY2023Q2 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
419947000
CY2022Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
496044000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
53000
CY2022Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
4998000
CY2022Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
491099000
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
154
CY2023Q2 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
326700000
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
149
CY2022Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
330900000
kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
27
CY2023Q2 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
71400000
CY2022 kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
36
CY2022Q4 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
115000000
kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
138
CY2023Q2 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
315200000
kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
49
CY2023Q2 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
104800000
CY2022 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
118
CY2022Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
338800000
CY2022 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
81
CY2022Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
152300000
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
us-gaap Availableforsale Securities Sold At Par
AvailableforsaleSecuritiesSoldAtPar
0
CY2023Q2 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2022Q4 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
kymr Cost Reimbursement Payment Received
CostReimbursementPaymentReceived
5900000
CY2023Q2 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
4100000
kymr Remaining Research Term Of Collaboration
RemainingResearchTermOfCollaboration
P2Y6M
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
2537000
kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
13299000
kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
11714000
CY2023Q2 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
4122000
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
63260000
kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
7442000
kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-25979000
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
44723000
CY2023Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
36185000
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
20227000
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8691000
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6893000
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
27494000
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
13334000
CY2023Q2 us-gaap Depreciation
Depreciation
900000
CY2022Q2 us-gaap Depreciation
Depreciation
700000
us-gaap Depreciation
Depreciation
1800000
us-gaap Depreciation
Depreciation
1400000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
400000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
700000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
600000
CY2023Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
2521000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
524000
us-gaap Operating Lease Cost
OperatingLeaseCost
5042000
us-gaap Operating Lease Cost
OperatingLeaseCost
1047000
CY2023Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
370000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
279000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
739000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
558000
CY2023Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
44000
CY2022Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
40000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
96000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
86000
CY2023Q2 us-gaap Variable Lease Cost
VariableLeaseCost
220000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
244000
us-gaap Variable Lease Cost
VariableLeaseCost
440000
us-gaap Variable Lease Cost
VariableLeaseCost
573000
CY2023Q2 us-gaap Lease Cost
LeaseCost
3155000
CY2022Q2 us-gaap Lease Cost
LeaseCost
1087000
us-gaap Lease Cost
LeaseCost
6317000
us-gaap Lease Cost
LeaseCost
2264000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
1320000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
1281000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
661000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
489000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
96000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
86000
CY2023Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y7M9D
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y10M2D
CY2023Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y2M15D
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y9M14D
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0882
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.085
CY2022Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0874
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
10618000
CY2023Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
705000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
11496000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
839000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12142000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
402000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12506000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
133000
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12881000
CY2023Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
100000
CY2023Q2 kymr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
85142000
CY2023Q2 kymr Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
0
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
123549000
CY2023Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
2179000
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
50481000
CY2023Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
186000
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
73068000
CY2023Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
1993000
CY2023Q2 kymr Undiscounted Future Lease Payments
UndiscountedFutureLeasePayments
12000000
CY2023Q2 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
12153000
CY2022Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
16975000
CY2023Q2 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
4951000
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8149000
CY2023Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3269000
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1971000
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2117000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
407000
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
22490000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27502000
CY2023Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y11M12D
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M29D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0371
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.03
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0406
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0187
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11181000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9622000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20565000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17495000
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
100000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-38799000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-40257000
us-gaap Net Income Loss
NetIncomeLoss
-79727000
us-gaap Net Income Loss
NetIncomeLoss
-76941000
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58326963
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58326963
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51772440
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51772440
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58257387
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58257387
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
51712081
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51712081
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.67
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.67
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.78
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.78
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.37
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.37
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.49
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.49
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8841699
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7429756
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
true
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Trd Arr Ind Name
TrdArrIndName
Jeffrey Albers
ecd Trd Arr Ind Title
TrdArrIndTitle
Director
ecd Trd Arr Adoption Date
TrdArrAdoptionDate
June 22, 2023
ecd Trd Arr Termination Date
TrdArrTerminationDate
September 1, 2024
CY2023Q2 ecd Trd Arr Securities Agg Avail Amt
TrdArrSecuritiesAggAvailAmt
22500

Files In Submission

Name View Source Status
kymr-20230630_def.xml Edgar Link unprocessable
kymr-20230630_lab.xml Edgar Link unprocessable
0000950170-23-037581-index-headers.html Edgar Link pending
0000950170-23-037581-index.html Edgar Link pending
0000950170-23-037581.txt Edgar Link pending
0000950170-23-037581-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kymr-20230630.htm Edgar Link pending
kymr-20230630.xsd Edgar Link pending
kymr-ex31_1.htm Edgar Link pending
kymr-ex31_2.htm Edgar Link pending
kymr-ex32_1.htm Edgar Link pending
kymr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
kymr-20230630_pre.xml Edgar Link unprocessable
kymr-20230630_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kymr-20230630_cal.xml Edgar Link unprocessable